for the following products
4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl)-2-fluoro-N-methylbenzamide | Apalutamide | Apalutamide-13C-D3 | ARN-509 and Apalutamide (aRn-509)
We are one of the world leading companies in manufacturing pharmaceutical standards, including stable-isotope labeled internal standards, metabolites, degradation compounds/impurities, and inhibitor reference compounds. Our products are widely used in Bioanalysis (BA) for preclinical/early stage clinical studies and Bioequivalence (BE) studies for generic drug development.
